ENST00000372348.9:c.136+23723C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000372348.9(ABL1):​c.136+23723C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 151,948 control chromosomes in the GnomAD database, including 3,440 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3440 hom., cov: 31)

Consequence

ABL1
ENST00000372348.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.144

Publications

4 publications found
Variant links:
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
  • congenital heart defects and skeletal malformations syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • bone development disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABL1NM_007313.3 linkc.136+23723C>T intron_variant Intron 1 of 10 NP_009297.2 P00519-2Q59FK4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABL1ENST00000372348.9 linkc.136+23723C>T intron_variant Intron 1 of 10 1 ENSP00000361423.2 P00519-2
ABL1ENST00000393293.4 linkc.136+23723C>T intron_variant Intron 1 of 1 5 ENSP00000376971.4 R4GRW0

Frequencies

GnomAD3 genomes
AF:
0.189
AC:
28700
AN:
151830
Hom.:
3443
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0522
Gnomad AMI
AF:
0.331
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.373
Gnomad EAS
AF:
0.0915
Gnomad SAS
AF:
0.243
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.382
Gnomad NFE
AF:
0.261
Gnomad OTH
AF:
0.239
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.189
AC:
28689
AN:
151948
Hom.:
3440
Cov.:
31
AF XY:
0.186
AC XY:
13848
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.0520
AC:
2155
AN:
41446
American (AMR)
AF:
0.198
AC:
3013
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
1294
AN:
3468
East Asian (EAS)
AF:
0.0917
AC:
475
AN:
5178
South Asian (SAS)
AF:
0.244
AC:
1170
AN:
4804
European-Finnish (FIN)
AF:
0.185
AC:
1944
AN:
10528
Middle Eastern (MID)
AF:
0.384
AC:
112
AN:
292
European-Non Finnish (NFE)
AF:
0.261
AC:
17729
AN:
67966
Other (OTH)
AF:
0.236
AC:
496
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1146
2293
3439
4586
5732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.164
Hom.:
650
Bravo
AF:
0.186
Asia WGS
AF:
0.147
AC:
515
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.3
DANN
Benign
0.33
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2583845; hg19: chr9-133613565; API